Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) FCF Margin (2020 - 2025)

Historic FCF Margin for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to 5.83%.

  • RxSight's FCF Margin fell 45400.0% to 5.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.62%, marking a year-over-year increase of 55600.0%. This contributed to the annual value of 16.0% for FY2024, which is 361000.0% up from last year.
  • According to the latest figures from Q3 2025, RxSight's FCF Margin is 5.83%, which was down 45400.0% from 17.58% recorded in Q2 2025.
  • In the past 5 years, RxSight's FCF Margin registered a high of 1.28% during Q3 2024, and its lowest value of 308.55% during Q1 2021.
  • Over the past 5 years, RxSight's median FCF Margin value was 45.02% (recorded in 2023), while the average stood at 93.99%.
  • Its FCF Margin has fluctuated over the past 5 years, first plummeted by -2009000bps in 2021, then surged by 1368400bps in 2022.
  • Quarter analysis of 5 years shows RxSight's FCF Margin stood at 107.84% in 2021, then rose by 18bps to 88.36% in 2022, then soared by 61bps to 34.61% in 2023, then surged by 63bps to 12.7% in 2024, then soared by 54bps to 5.83% in 2025.
  • Its FCF Margin was 5.83% in Q3 2025, compared to 17.58% in Q2 2025 and 24.82% in Q1 2025.